Evidence map›Paper›PMID 36837487›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells.

Mahsa Naghashpour, Dian Dayer, Hadi Karami, Mahshid Naghashpour, Mahin Taheri Moghadam, Seyed Mohammad Jafar Haeri, Katsuhiko Suzuki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer.World journal of gastrointestinal surgery · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mahsa NaghashpourDepartment of Anatomical Sciences, Medical School, Arak University of Medical Sciences, Arak 38481-7-6341, Iran.
Dian DayerCellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 61357-15794, Iran.
Hadi KaramiDepartment of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak 38481-7-6341, Iran.
Mahshid NaghashpourDepartment of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan 6313833177, Iran.
Mahin Taheri MoghadamDepartment of Anatomical Science, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 61357-15753, Iran.
Seyed Mohammad Jafar HaeriDepartment of Anatomical Sciences, Medical School, Arak University of Medical Sciences, Arak 38481-7-6341, Iran.
Katsuhiko SuzukiFaculty of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa 359-1192, Japan.ORCID 0000-0002-6572-5809
Arak University of Medical Sciences · IRAhvaz Jundishapur University of Medical Sciences · IRWaseda University · JP

Funding

Voice Chancellor for Research, Arak University of Medical Sciences, Arak, Iran 6345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LignansStomach NeoplasmsApoptosisBiphenyl CompoundsCell Line, TumorCell ProliferationCisplatinHumansBiphenyl CompoundsCisplatinLignansmagnololcisplatingastric cancermagnololMKN-45

Identifiers

PMID36837487
PMCPMC9963572
OpenAlexW4318817272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.